MINNEAPOLIS (WCCO) — The University of Minnesota on Thursday announced that a promising new brain cancer clinical trial is underway. It’s Phase I of the first-in-human trial, and university physicians and scientists are enrolling patients with glioblastoma, which is...
By Dr. Paul Camarata – Clinical Service Chief, Neurosurgery, The University of Kansas Health System Brain tumors are understandably perceived as quite a grim diagnosis. Medical, surgical and technical advances, along with discoveries in research, provide more options...
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows. The study is the first to demonstrate an...
Glioblastomas are the most common malignant brain tumors in adults. Treatment options are extremely limited and usually not effective, leading to death for most patients within 12-18 months of diagnosis. Read more…...
No matter where you are in your journey, CBTF is here to help. If you’re interested in finding out more about CBTF programming and support, please fill out our form to be connected to our team.
